Opioids 360

Sarah A. See; Eric S. See

doi:10.5771/9781538192580

Keywords

Search publication

Bibliographic data

Copyright year: 2024
ISBN-Print: 978-1-5381-9256-6
ISBN-Online: 978-1-5381-9258-0
Publisher: Rowman & Littlefield, Lanham
Language: English
Pages: 220
Product type: Edited Book

1. Contents No access
2. Acknowledgments No access
3. Foreword No access
4. Introduction No access
1. Early Uses of Opium No access
2. The Origins of Addiction No access
3. Modern Addiction No access
4. Stigma No access
5. Conclusion No access
6. References No access
1. Rising Death Tolls No access
2. Background: Cultural Acceptance of Consuming Opioids No access
3. Origins of the Epidemic No access
4. The American Opioid Market: An Overview No access
5. Expanding Consumer Information and Accessibility No access
6. Incentivized Healthcare Providers No access
7. A Vulnerable, Fragmented Health System No access
8. Three Common Explanations: Market Demand, Market Supply, and Inadequate Access No access
9. The Demand Side Explanation for the Opioid Market No access
10. The Supply Side Explanation for the Opioid Market No access
11. The Economically Disadvantaged Explanation No access
12. Polysubstance Abuse No access
13. Increasing Interconnectivity Aides Contraband Channels No access
14. China’s Role No access
15. Precursor Chemicals and China No access
16. The Transnational Role: Chinese Adaptation No access
17. India No access
18. 1. Addressing Supply: Endogenous and Exogenous Factors No access
19. International Cooperation: Negotiating with Beijing No access
20. Conclusion No access
21. References No access
1. 1. The Profit Motive No access
  2. Substitutes and Complements No access
  3. Secondary Effects No access
  4. Models of International Trade No access
  5. Augmenting Trade Models with Political Intrigue No access
  6. Legal Technicalities and Chemical Properties No access
  7. International Trade and Demand for Opioids No access
  8. Areas Affected by Trade-Related Job Losses No access
  9. Medical Tourism No access
2. 1. International Trade and the Supply of Opioids No access
  2. Chinese Money Laundering Networks and the US Fentanyl Trade No access
  3. Internationally Sourced Substitutes for Opioids No access
  4. Complications of International Politics No access
3. Conclusion No access
4. References No access
1. Background No access
2. An Alternative Theory No access
3. Market Dynamics and Regulatory Failures No access
4. Conclusion: Deregulation No access
5. References No access
1. The Opioid Epidemic No access
2. Criticism of Coverage No access
3. 1. Social Media No access
  2. Solutions-Based Journalism No access
4. Questions and Discussion No access
5. Conclusion No access
6. References No access
1. Background of the Public Health Crisis and Conceptual Framework No access
2. Nature of the Lawsuits and Setbacks Against Industry No access
3. New Strategies Against Industry and Successful Settlements No access
4. The European Counterpart and What the United States Can Learn No access
5. References No access
1. The Crisis Quantified No access
2. Access to Naloxone No access
3. National Drug Early Warning System (NDEWS) No access
4. Operation Safe Station No access
5. Prescription Drug Monitoring Program No access
6. Good Samaritan Law No access
7. Conclusion No access
8. References No access
1. CONCLUSION No access
2. References No access
1. Issues Regarding Pain Management and Opioids No access
2. Case Study Plus Variations No access
3. Virtue Ethics No access
4. Virtue Ethics and the Issue of Opioid Treatment for Opioid Addicts in Severe Pain No access
5. References No access
1. Harm-Reduction and Regulatory Methods No access
2. Case Study: John’s Struggle with Opioid Abuse and the Role of Harm Reduction No access
3. Harm-Reduction Approaches in Portugal No access
4. Harm-Reduction Approaches in the United Kingdom No access
5. Harm-Reduction Approaches in the United States No access
6. Harm-Reduction Approaches in Canada No access
7. Comparison of Harm-Reduction Successes and Challenges Across Countries No access
8. Physiological Pathways to Opioid Addiction No access
9. Opioid Receptors and Their Role in Addiction No access
10. The Reward Pathway and Dopamine Release No access
11. Tolerance, Dependence, and Withdrawal No access
12. Neuroplasticity in Opioid Addiction No access
13. Stress and Coping No access
14. Negative Affect, Anxiety, and Depression No access
15. Social Factors and Peer Influence No access
16. Personality Traits and Impulsivity No access
17. The Role of Corporate Greed and Ineffective Regulation No access
18. The Role of Medical Over-Prescription in the Opioid Epidemic No access
19. The Role of Dentists in Opioid Prescribing No access
20. The Role of Nurse Practitioners and Physician Assistants in Opioid Prescribing No access
21. Socioeconomic Factors and the Opioid Crisis No access
22. Alternative Perspectives on Addiction: Gabor Maté and the Rat Park Experiment No access
23. Conclusion No access
24. References No access
1. Brief History of the Problem No access
2. 1. Dosage No access
  2. Availability No access
  3. Lack of Regulations No access
3. American Pain No access
4. 1. Step One, the scoring of different types of evidence: No access
  2. Step Two, the creation of five clinical questions: No access
  3. Step Three, three general assessments: No access
5. Conclusion and Recommendations No access
6. References No access
1. CONCLUSION No access
2. References No access
1. Posttraumatic Stress Disorder No access
2. Anxiety No access
3. Depression No access
4. Attention-Deficit/Hyperactivity Disorder No access
5. Nonmedical Use of Prescription Drugs No access
6. Conclusion No access
7. References No access
Index No access Pages 215 - 216
About the Contributors No access Pages 217 - 220